Jeffrey Cohen
- Pathology and Forensic Medicine top 0.2%
- Neurology top 1%
- Oncology top 5%
- Rheumatology top 1%
- Immunology top 5%
- Co-authors
- Eva HavrdováDouglas L. ArnoldKrzysztof SelmajAlasdair ColesDavid MargolinD. A. S. CompstonEdward FoxMichael Panzara
- Topics
- Multiple Sclerosis Research Studies (37 papers)Rheumatoid Arthritis Research and Therapies (12 papers)Peripheral Neuropathies and Disorders (8 papers)
- Partner nations
- United StatesUnited KingdomCzechia
In The Last Decade
Jeffrey Cohen
49 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Pathology and Forensic Medicine 2.4k
- Neurology 924
- Oncology 776
- Rheumatology 709
- Immunology 701
Countries citing papers authored by Jeffrey Cohen
This map shows the geographic impact of Jeffrey Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Cohen more than expected).
Fields of papers citing papers by Jeffrey Cohen
This network shows the impact of papers produced by Jeffrey Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Cohen. The network helps show where Jeffrey Cohen may publish in the future.
Co-authorship network of co-authors of Jeffrey Cohen
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Cohen. A scholar is included among the top collaborators of Jeffrey Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Cohen. Jeffrey Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 22 | |
| 6 | 176 | |
| 7 | 2 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 5 | |
| 11 | 2 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 3 | |
| 15 | 11 | |
| 16 | Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trialbreakdown → | 883 |
| 17 | Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trialbreakdown → | 884 |
| 18 | 20 | |
| 19 | 15 | |
| 20 | 141 |
About Jeffrey Cohen
Jeffrey Cohen is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology, having authored 52 papers that have together received 3.0k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (37 papers), Rheumatoid Arthritis Research and Therapies (12 papers) and Peripheral Neuropathies and Disorders (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.4k citations), Neurology (924 citations) and Rheumatology (709 citations). Jeffrey Cohen has collaborated with scholars based in United States, United Kingdom and Czechia. Frequent co-authors include Eva Havrdová, Douglas L. Arnold, Krzysztof Selmaj, Alasdair Coles, David Margolin, D. A. S. Compston, Edward Fox, Michael Panzara, Howard L. Weiner and Hans-Peter Hartung. Their work appears in journals such as The Lancet, Neurology and Annals of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.